Skip to main content

GSA CAPITAL PARTNERS LLP

Position in ANIK — Anika Therapeutics, Inc.

CIK 1362033 LONDON, X0

Position in ANIK

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$311,315
-$861,700 QoQ
Shares Held
21,470
-82.4% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $10,668,998 across 16 Drug Manufacturers - Specialty & Generic names. ANIK ranks #13 (2.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANIK

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $311,315 21,470
2025-12-31 $1,173,015 122,062
2025-09-30 $392,384 41,743
2024-12-31 $190,540 11,576
2024-09-30 $777,432 31,475
2024-06-30 $1,002,105 39,562
2024-03-31 $1,113,459 43,837
2023-12-31 $1,322,800 58,376
2023-09-30 $962,015 51,638
2023-03-31 $537,896 18,729
2021-12-31 $348,160 9,717
2021-09-30 $826,557 19,421
2021-06-30 $1,768,612 40,855
2021-03-31 $590,231 14,470
2020-03-31 $325,902 11,273